Press Release U.S. FDA Grants Accelerated Approval to Bristol Myers Squibb’s First CELMoD Therapy ZENBEXUS™, in Combination with Daratumumab and Hyaluronidase-fihj and Dexamethasone (ZDd) for Patients with Multiple Myeloma, as Early as First Relapse 10 hours ago
Press Release Afya Limited Announces Second-Quarter and First-Half 2026 Financial Results 12 hours ago
Press Release flyExclusive Reports Record Second Quarter Revenue and Third Consecutive Quarter of Positive Adjusted EBITDA 12 hours ago
Press Release Health Optimization & Longevity Arrives in Boulder: Next Health Celebrates Grand Opening with Live Podcast Recording Featuring Dr. Darshan Shah and Ben Greenfield 12 hours ago
Press Release Wolf-Gordon Expands Its Interior Surfaces Platform with Two Strategic Acquisitions: Andor Willow and Look Walls & Interiors 13 hours ago
Press Release WaterBridge Announces Pricing of Upsized $150,000,000 Offering of Additional 6.500% Senior Notes due 2033 13 hours ago